Neat Digest  ·  Archive  ·  Open in app ↗

Eli Lilly's Retatrutide Meets Primary Endpoints in Obesity Trial

Score 6.5/10 · Significant · Health · 1 sources · May 21, 2026
Eli Lilly's Retatrutide Meets Primary Endpoints in Obesity Trial

Summary: Eli Lilly announced that its next-generation weight loss drug,...

Sources on this story

Reported by 1 sources, including:

  • CNBC